Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Purpose of This Study is to Determine if the 9zest App for Parkinson's Disease (PD) is Feasible, Safe, and Efficacious When Used Independently by Individuals With Parkinson's Disease

NCT03459586 is registered in ClinicalTrials.gov with 9zest. Inc. as lead sponsor.

NCT NCT03459586
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03459586 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Purpose of This Study is to Determine if the 9zest App for Parkinson's Disease (PD) is Feasible, Safe, and Efficacious When Used Independently by Individuals With Parkinson's Disease
Lead sponsor
9zest. Inc.
Phase
Not applicable
Overall status
Unknown status
Start date
February 28, 2018
Completion date
December 31, 2018
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson disease